Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.

被引：0
|
作者：
Heise, T
Nosek, L
Draeger, E
Ronn, BB
Kapitza, C
Heinemann, L
机构：
[1] Profil Inst Stoffwechselforch GmbH, Neuss, Germany
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：A6 / A7
页数：2
相关论文
共 50 条
  • [1] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
    Heise, T
    Nosek, L
    Draeger, E
    Stender, A
    Ronn, BB
    Kapitza, C
    Heinemann, L
    [J]. DIABETES, 2003, 52 : A121 - A121
  • [2] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    [J]. DIABETES, 2004, 53 (06) : 1614 - 1620
  • [3] Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes
    Wutte, A
    Plank, J
    Sinner, F
    Druml, T
    Sommer, R
    Zdravkovic, M
    Ronn, BB
    Draeger, E
    Pieber, TR
    [J]. DIABETES, 2004, 53 : A152 - A152
  • [4] Lower within-subject variability in pharmacokinetic profiles of insulin detemir in comparison to insulin glargine in children and adolescents with type I diabetes
    Danne, T.
    Endahl, L.
    Haahr, H.
    Datz, N.
    Nestoris, C.
    Westergaard, L.
    Kordonouri, O.
    [J]. DIABETOLOGIA, 2007, 50 : S84 - S84
  • [5] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
    Haak, T
    Tiengo, A
    Draeger, E
    Suntum, M
    Waldhäusl, W
    [J]. DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
  • [6] Beneficial effects of insulin glargine compared to NPH in subjects with type 1 diabetes.
    Hershon, K
    Blevins, T
    Donley, D
    Littlejohn, C
    [J]. DIABETOLOGIA, 2001, 44 : A15 - A15
  • [7] Insulin detemir shows a lower glucose variability compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring
    Jones, D. R.
    Clauson, P.
    Ong, S.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2006, 49 : 580 - 580
  • [8] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [9] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
  • [10] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
    Kolendorf, K
    Pavlic-Renar, I
    San-Teusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETES, 2004, 53 : A130 - A131
12345